An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients

Detalhes bibliográficos
Main Authors:	Littleton, E, Palace, J
Formato:	Conference item
Publicado em:	2005

Registos relacionados

Modafinil for multiple sclerosis fatigue: does it work?
Por: Littleton, E, et al.
Publicado em: (2010)

Assessing the impacts of L-carnitine and modafinil on fatigue in Iraqi multiple sclerosis patients
Por: Ahmed Hamza Al-Shammari, et al.
Publicado em: (2023-01-01)

The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta‐analysis of controlled clinical trials
Por: Shamas Ghazanfar, et al.
Publicado em: (2024-07-01)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
Por: Bibani, R, et al.
Publicado em: (2012)

Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
Por: Bibani, R, et al.
Publicado em: (2012)

An approach to the identification of targets of autoantibodies in multiple sclerosis
Por: Littleton, E, et al.
Publicado em: (2004)

Towards defining antigenic targets for antibodies in multiple sclerosis
Por: Littleton, E, et al.
Publicado em: (2006)

Use of Modafinil in Psychiatric Disorders
Por: Mehmet Hanifi Kokacya, et al.
Publicado em: (2016-03-01)

New and old treatments for multiple sclerosis.
Por: Palace, J
Publicado em: (1998)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.
Por: Spathis, A, et al.
Publicado em: (2014)

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial
Por: Spathis, A, et al.
Publicado em: (2014)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
Por: Littleton, E, et al.
Publicado em: (2006)

New treatments and azathioprine in multiple sclerosis.
Por: Palace, J, et al.
Publicado em: (1997)

Short- and Long-Term Efficacy of Modafinil at Improving Quality of Life in Stroke Survivors: A Post Hoc Sub Study of the Modafinil in Debilitating Fatigue After Stroke Trial
Por: Thomas P. Lillicrap, et al.
Publicado em: (2018-04-01)

Modafinil and Learning and Memory- Is there a Connection? Evaluation of the Effect of Modafinil on Learning and Memory in Wistar Rats
Por: Mnnat Gill, et al.
Publicado em: (2019-10-01)

The successful treatment of hypercapnic respiratory failure with oral modafinil
Por: Parnell H, et al.
Publicado em: (2014-04-01)

Comparison of effects of modafinil and caffeine on fatigue-vulnerable and fatigue-resistant aircrew after a limited period of sleep deprivation
Por: Yara Q. Wingelaar-Jagt, et al.
Publicado em: (2024-01-01)

Sociodemographic and Clinical Determinants of Fatigue in Multiple Sclerosis
Por: Smaranda Maier, et al.
Publicado em: (2023-10-01)

Modafinil-induced Fixed Drug Eruption
Por: Girish Vasant Gaikwad, et al.
Publicado em: (2012-01-01)

Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
Por: Talbot, K, et al.
Publicado em: (2003)

Positive effect of modafinil on daytime somnolence on patients with Myotonic Dystrophy
Por: Talbot, K, et al.
Publicado em: (2002)

Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses
Por: Crawford A, et al.
Publicado em: (2014-08-01)

Modafinil-Induced Increases in Brain Dopamine Levels
Por: J Gordon Millichap
Publicado em: (2009-04-01)

Modafinil Trial in Attention Deficit Hyperactivity Disorder
Por: J Gordon Millichap
Publicado em: (2005-12-01)

Making the diagnosis of multiple sclerosis.
Por: Palace, J
Publicado em: (2001)

Modafinil does not reduce cocaine use in methadone-maintained individuals
Por: Elise E. DeVito, et al.
Publicado em: (2022-03-01)

Combination of modafinil and d-Amphetamine for the treatment of cocaine dependence: A preliminary investigation
Por: Joy M Schmitz, et al.
Publicado em: (2012-08-01)

Modafinil Induced Psychosis in a Patient with Bipolar 1 Depression
Por: Alexander A. DiSciullo, et al.
Publicado em: (2018-01-01)

A randomised controlled trial of modafinil for treatment of daytime somnolence in myotonic dystrophy
Por: Talbot, K, et al.
Publicado em: (2003)

Modafinil decreases anxiety-like behaviour in zebrafish
Por: Adrian Johnson, et al.
Publicado em: (2017-02-01)

Fatigue and Oropharyngeal Dysphagia in Patients with Multiple Sclerosis
Por: Anna Alice dos Santos Leite, et al.
Publicado em: (2020-04-01)

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis.
Por: Ping Sheng, et al.
Publicado em: (2013-01-01)

Modafinil-excipient compatibility study using differential scanning calorimetry
Por: Derar Omari, et al.
Publicado em: (2023-01-01)

The UK Multiple Sclerosis database.
Por: Palace, J, et al.
Publicado em: (1999)

Fatigue in Multiple Sclerosis: (An update)
Por: Hossein Zarei
Publicado em: (2007-10-01)

Guidelines for differential diagnosis of suspected multiple sclerosis.
Por: Palace, J
Publicado em: (2009)

Effects of modafinil on emotional processing in first episode psychosis.
Por: Scoriels, L, et al.
Publicado em: (2011)

Factors affecting fatigue progression in multiple sclerosis patients
Por: Dima Machtoub, et al.
Publicado em: (2024-12-01)

Cataplexy as a side effect of modafinil in a patient without narcolepsy
Por: Eduardo Lopes, et al.
Publicado em: (2014-03-01)

Multiple sclerosis, fatigue and sleep disorders: beyond the clinical relapses
Por: Tarso Adoni
Publicado em: (2016-06-01)